I am a breastfeeding mother and i want to know if it is safe to use 6-(1-Piperidinyl)-2,4-pyrimidinediamine 3-oxide? Is 6-(1-Piperidinyl)-2,4-pyrimidinediamine 3-oxide safe for nursing mother and child? Does 6-(1-Piperidinyl)-2,4-pyrimidinediamine 3-oxide extracts into breast milk? Does 6-(1-Piperidinyl)-2,4-pyrimidinediamine 3-oxide has any long term or short term side effects on infants? Can 6-(1-Piperidinyl)-2,4-pyrimidinediamine 3-oxide influence milk supply or can 6-(1-Piperidinyl)-2,4-pyrimidinediamine 3-oxide decrease milk supply in lactating mothers?
- DrLact safety Score for 6-(1-Piperidinyl)-2,4-pyrimidinediamine 3-oxide is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of 6-(1-Piperidinyl)-2,4-pyrimidinediamine 3-oxide is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that 6-(1-Piperidinyl)-2,4-pyrimidinediamine 3-oxide does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of 6-(1-Piperidinyl)-2,4-pyrimidinediamine 3-oxide safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
It is excreted into breast milk in non-significant amount without side-effects observed among infants whose mothers were taking this medication. This small risk can further be minimized by avoiding to nurse one hour after taking the medication, a time at which milk level is higher (4, 10, 20 and 40 times higher than if occurs within 3, 6, 9 and 12 hours respectively) The American Academy of Pediatrics states that it is usually compatible with breastfeeding. Because, few published experience is available, it would be preferred better known options, especially within the neonatal period or in case of prematurity.
Because of the minimal amount of information on this potent agent, use 6-(1-Piperidinyl)-2,4-pyrimidinediamine 3-oxide with caution, particularly when therapy involves a large maternal dosage or breastfeeding a newborn. Topical 6-(1-Piperidinyl)-2,4-pyrimidinediamine 3-oxide should pose low risk to the breastfed infant.
No hypertrichosis or other abnormal signs were seen in one infant breastfed for 2 months of maternal 6-(1-Piperidinyl)-2,4-pyrimidinediamine 3-oxide therapy.[1]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.